SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-067197
Filing Date
2018-03-01
Accepted
2018-03-01 16:16:54
Documents
3
Period of Report
2018-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d539265d8k.htm 8-K 16063
2 EX-99.1 d539265dex991.htm EX-99.1 62728
3 GRAPHIC g539265g0301234851322.jpg GRAPHIC 4044
  Complete submission text file 0001193125-18-067197.txt   85786
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 18657519
SIC: 2834 Pharmaceutical Preparations